【WEF】2024创建充满活力的食品创新生态系统-以色列如何跨部门推进替代蛋白产业发展白皮书_24页_1mb

Creating a Vibrant Food Innovation Ecosystem: How Israel Is Advancing Alternative Proteins Across Sectors
Introduction
Israel is emerging as a global leader in alternative proteins (plant-based, cultivated meat, fermentation-derived proteins). Driven by climate change concerns, food security needs, and technological advancements, the country is strategically investing to build a resilient ecosystem.

Government Role & Strategic Framework

1. Prioritizing R&D: Alternative proteins are deemed a top national research priority alongside health and energy.
2. Financial Support: The Innovation Authority funds startups, consortia, and R&D centers.
3. Regulatory Clarity: Israel was the first to approve cultivated beef, fostering innovation while ensuring safety.
4. Public-Private Collaboration: Partnerships like the Cultivated Meat Consortium (14 companies + 10 academic labs) accelerate development.

Key Pillars of the Ecosystem

• Basic Research: Universities like Hebrew University and Technion lead foundational studies.
• Applied R&D: Focuses on production technologies through incubators (e.g., The Kitchen, Fresh Start).
• Scaling Infrastructure: CDMOs like YDLabs provide pilot-scale facilities for process optimization.

Challenges & Solutions

1. Cost Competitiveness: High CAPEX demands institutional investment incentives.
2. Regulatory Uncertainty: Clear frameworks akin to Europe and Singapore are needed globally.
3. Market Size Limitations: Israel’s reliance on exports incentivizes regional partnerships (e.g., BIRD Foundation).

Global Collaboration Imperative
Countries like Denmark and the Netherlands are following Israel’s lead, emphasizing coordinated investments to meet a projected $10B annual public funding target for alternative protein R&D by 2030.

Conclusion
Israel’s hybrid model—combining academic expertise, targeted government intervention, and private enterprise—offers a replicable blueprint. Addressing climate goals, resource scarcity, and technological innovation requires a unified global strategy for alternative proteins, with Israel paving the way.